Benzinga | Jul 15, 2020 07:02AM EDT

Rosenblatt Upgrades Xylem to Buy, Raises Price Target to $85

Rosenblatt analyst Scott Graham upgrades Xylem (NYSE:XYL) from Neutral to Buy and raises the price target from $70 to $85.